Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a)
Condition(s):Bioequivalence; HealthyLast Updated:January 10, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Bioequivalence; HealthyLast Updated:January 10, 2020Completed
Condition(s):Healthy Subjects; Pharmacokinetics; PharmacodynamicsLast Updated:August 23, 2021Completed
Condition(s):HealthyLast Updated:May 4, 2016Completed
Condition(s):Multiple SclerosisLast Updated:June 10, 2009Completed
Condition(s):Alzheimer’s DiseaseLast Updated:February 13, 2014Completed
Condition(s):Multiple SclerosisLast Updated:February 19, 2014Completed
Condition(s):Relapsing-Remitting Multiple SclerosisLast Updated:March 18, 2014Completed
Condition(s):Relapsing Multiple Sclerosis; Clinically Isolated SyndromeLast Updated:March 30, 2018Completed
Condition(s):HealthyLast Updated:February 25, 2013Completed
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:September 20, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.